logo

RKDA

Arcadia Biosciences·NASDAQ
--
--(--)
--
--(--)

RKDA fundamentals

Arcadia Biosciences (RKDA) released its earnings on Nov 7, 2025: revenue was 1.30M (YoY -15.29%), missed estimates; EPS was -0.8479 (YoY +28.14%), missed estimates.
Revenue / YoY
1.30M
-15.29%
EPS / YoY
-0.8479
+28.14%
Report date
Nov 7, 2025
EPS
Q2,undefined
Q3,2017
Q4,2017
Q1,2018
Q2,2018
Q3,2018
Q4,2018
Q1,2019
Q2,2019
Q3,2019
Q4,2019
Q1,2020
Q2,2020
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
11.6-41.6-24364.4-13.83456.6414-16.8-8.5913-6.8-4.8-6.31-7.7950.61-1.89-2.1-1.780.78-1.18-2.981.9-3.26-0.8479
Forecast
-21.8-23.4667-21.7333-16.4-13.7333-10.9333-11.8-12-13.6-11.6-8.4-6.8-6.6-4.845-2.93-2.585-2.2151.55-0.81-0.89-0.98-0.79-0.54
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+153.21%
-77.27%
-10.43%
+319.51%
+132.04%
-26.54%
+156.28%
-40.00%
+36.83%
+41.38%
+42.86%
+7.21%
-18.11%
+112.59%
+35.49%
+18.76%
+19.64%
-49.68%
-45.68%
-234.83%
+293.88%
-312.66%
-57.02%
Revenue
Q2,undefined
Q3,2017
Q4,2017
Q1,2018
Q2,2018
Q3,2018
Q4,2018
Q1,2019
Q2,2019
Q3,2019
Q4,2019
Q1,2020
Q2,2020
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
----------------------309.00K281.00K314.00K7.13M828.00K1.41M2.38M2.17M3.22M3.86M1.88M1.00M1.51M1.39M1.60M1.17M1.25M1.31M1.54M1.22M1.20M1.46M1.30M
Forecast
----------------------800.00K1.86M1.14M1.26M734.33K1.69M2.51M3.33M1.90M2.30M2.67M2.00M1.40M1.60M1.55M1.75M1.20M950.00K1.40M1.15M1.30M1.60M1.90M
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-61.38%
-84.86%
-72.50%
+467.68%
+12.76%
-16.81%
-5.28%
-34.84%
+69.56%
+67.74%
-29.62%
-50.00%
+7.79%
-13.19%
+3.33%
-33.14%
+4.58%
+37.47%
+9.79%
+5.74%
-7.69%
-9.06%
-31.47%

Earnings Call